This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peyton Howell
Executive VP, CCO and CSO at Parexel


Ms. Howell joined Parexel in May 2018 and provides leadership for the company’s Commercial and Corporate Business Development, Corporate Strategy, Marketing, Corporate Communications and Consulting businesses, including Regulatory & Access. She has more than 25 years of leadership experience in the healthcare industry successfully delivering solutions to meet customer needs. Prior to joining Parexel, Ms. Howell held several leadership positions with AmerisourceBergen, a Fortune 20 company. Most recently she served as President for Health Systems and Specialty Care Solutions, a $50B business unit with market-leading share of specialty and biotech products and solutions for physicians, health systems and specialty pharmacy customers. Also at Amerisource Bergen, Ms. Howell was Executive Vice President & President, Global Sourcing and Manufacturer Relations, responsible for leadership of $150B in manufacturer sourcing and global relationships. In this role, she led the creation of a new sourcing entity in Bern, Switzerland to support global manufacturer relations and a joint venture with Walgreens. Ms. Howell also previously served as President, Consulting Services for the company, managing a portfolio of industry-leading pharma services (including acquisitions) focused on market access, reimbursement, patent programs, specialty pharmacy, specialty logistics and product commercialization. . Ms. Howell was a founder of Lash Group, growing the company from 200 to nearly 5,000 employees and serving as President for nearly 10 years following its acquisition by AmerisourceBergen. Ms. Howell holds a Masters’ in Healthcare Administration (MHA) from The Ohio State University and a Bachelor of Arts in Speech Communication from The University of Illinois at Urbana-Champaign. She serves on the Board of Directors of Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company.

Agenda Sessions

  • Patients first: A path to better outcomes for everyone

    On Demand